The benefits of early treatment are clear for both people living with HIV (PLWH) and the whole society. Last Wednesday, based on the findings of the largest clinical trial, federal health officials announced that the benefits of the early treatment are obvious. Besides, they also said that people with HIV should take antiretroviral drugs as soon as they are diagnosed.
This trial is a strong evidence to show that those who got treatment immediately were 53 percent less likely to be infected and develop AIDS or die during the trial. Therefore, the early treatment saves more lives. At present, according to the Centers for Disease Control and Prevention (C.D.C.), 450,000 of the estimated 1.2 million with HIV are on treatment. Although the influence of early treatment is sound and profound, only 37 percent of infected Americans had the access to get the prescriptions of the drugs. This small percentage is partly due to the limited access to HIV testing, health insurance. Therefore, people infected by AIDS could not afford the drugs or did not see doctors.
In addition, though the substantial evidence of the benefits of early treatment is defining, the shortage of funding is the main cause of a small amount of people living with HIV have the access to the early treatment — antiretroviral medicines. For instance, the Global Fund to Fight AIDS, Tuberculosis and Malaria constantly struggle to raise money.
It’s true that antiretroviral treatment (early treatment) is the best way to curb AIDS. The shortage of money is the mainly daunting challenge facing organizations targeting at HIV.
Photo credit from: http://www.bchdmi.org/cchs/hiv